These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35967385)

  • 21. Endogenous luminal surface adenosine signaling regulates duodenal bicarbonate secretion in rats.
    Ham M; Mizumori M; Watanabe C; Wang JH; Inoue T; Nakano T; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2010 Dec; 335(3):607-13. PubMed ID: 20805305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
    Kotulová J; Hajdúch M; Džubák P
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients.
    Spanevello RM; Mazzanti CM; Schmatz R; Thomé G; Bagatini M; Correa M; Rosa C; Stefanello N; Bellé LP; Moretto MB; Oliveira L; Morsch VM; Schetinger MR
    Clin Chim Acta; 2010 Feb; 411(3-4):210-4. PubMed ID: 19914228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease.
    Liberal R; Grant CR; Ma Y; Csizmadia E; Jiang ZG; Heneghan MA; Yee EU; Mieli-Vergani G; Vergani D; Robson SC; Longhi MS
    J Autoimmun; 2016 Aug; 72():102-12. PubMed ID: 27210814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canonical and non-canonical adenosinergic pathways.
    Ferretti E; Horenstein AL; Canzonetta C; Costa F; Morandi F
    Immunol Lett; 2019 Jan; 205():25-30. PubMed ID: 29550257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
    Hilchey SP; Kobie JJ; Cochran MR; Secor-Socha S; Wang JC; Hyrien O; Burack WR; Mosmann TR; Quataert SA; Bernstein SH
    J Immunol; 2009 Nov; 183(10):6157-66. PubMed ID: 19864600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
    Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
    Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Adenosine Receptors in Rare Neurodegenerative Diseases with Motor Symptoms.
    Beltran-Beltran V; Benetó N; Lapeña-Luzón T; Rodríguez LR; Pallardó FV; Gonzalez-Cabo P
    Curr Protein Pept Sci; 2021 Dec; 22(9):675-694. PubMed ID: 34514988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
    Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
    Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.
    Orian JM; D'Souza CS; Kocovski P; Krippner G; Hale MW; Wang X; Peter K
    Front Immunol; 2021; 12():620963. PubMed ID: 33679764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety issues of compounds acting on adenosinergic signalling.
    Schmidt J; Ferk P
    J Pharm Pharmacol; 2017 Jul; 69(7):790-806. PubMed ID: 28397249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
    Pacheco R; Martinez-Navio JM; Lejeune M; Climent N; Oliva H; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9583-8. PubMed ID: 15983379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting cancer-derived adenosine: new therapeutic approaches.
    Young A; Mittal D; Stagg J; Smyth MJ
    Cancer Discov; 2014 Aug; 4(8):879-88. PubMed ID: 25035124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The good and the bad of neuroinflammation in multiple sclerosis.
    Naegele M; Martin R
    Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system.
    Vindeirinho J; Costa GN; Correia MB; Cavadas C; Santos PF
    PLoS One; 2013; 8(6):e67499. PubMed ID: 23840723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
    Silva-Vilches C; Ring S; Mahnke K
    Front Immunol; 2018; 9():2581. PubMed ID: 30473700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The second brain: The connection between gut microbiota composition and multiple sclerosis.
    Farshbafnadi M; Agah E; Rezaei N
    J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R; McFarland HF
    Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.